David Brister, 45, joined Evotec as Chief Business Officer in October 2006. He brings 22 years of business experience to the Company, including 19 years in venture capital and private equity. He joined Evotec following a successful career in developing venture capital businesses at 3i and MVM. Prior to Evotec he was a Director at MVM, a venture capital business focused on seed and early stage healthcare investing, where he was one of the two key executives who established the business. During this time he was instrumental in the successful raising of £110 million for MVM's second life sciences fund. Prior to MVM, he was an Investment Director at 3i plc and before that held sales and commercial positions with Metal Box plc.
David Brister holds a BSc honours degree in Genetics & Zoology from Sheffield University, UK.